Most peptide-based drugs are ideally administered via injection to ensure consistent dosing and efficacy
Abstract Semaglutide is often optimized to maximize weight loss, yet it remains unclear whether long-term cardiovascular benefit is more closely associated with achieved weight reduction or therapeutic exposure
While talking to The New Indian Express, Dr Naval Vikram, Physician, Diabetologist and Professor in the Department of Medicine at AIIMS-Delhi, and Dr Preethi Mrinalini K, General and Laparoscopic Surgeon at Apollo First Med Hospitals, Chennai, expressed deep concerns about the likely misuse of the drug
semaglutide (1.0 mg and 2.0 mg) was studied by following 12-week dose escalation period, after which the active comparator group (1.0 mg) received additional placebo s.c
Novo Nordisk also said it continues to take action against entities that violate laws and regulations and put patient safety at risk